AU2002235786B2 - A method for mixed mode adsorption and mixed mode adsorbents - Google Patents

A method for mixed mode adsorption and mixed mode adsorbents Download PDF

Info

Publication number
AU2002235786B2
AU2002235786B2 AU2002235786A AU2002235786A AU2002235786B2 AU 2002235786 B2 AU2002235786 B2 AU 2002235786B2 AU 2002235786 A AU2002235786 A AU 2002235786A AU 2002235786 A AU2002235786 A AU 2002235786A AU 2002235786 B2 AU2002235786 B2 AU 2002235786B2
Authority
AU
Australia
Prior art keywords
substance
ligand
groups
ligands
charged
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU2002235786A
Other languages
English (en)
Other versions
AU2002235786A1 (en
Inventor
Makonnen Belew
Bo-Lennart Johansson
Jean-Luc Maloisel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytiva Bioprocess R&D AB
Original Assignee
Cytiva Bioprocess R&D AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytiva Bioprocess R&D AB filed Critical Cytiva Bioprocess R&D AB
Publication of AU2002235786A1 publication Critical patent/AU2002235786A1/en
Assigned to GE HEALTHCARE BIO-SCIENCES AB reassignment GE HEALTHCARE BIO-SCIENCES AB Request for Assignment Assignors: AMERSHAM BIOSCIENCES AB
Application granted granted Critical
Publication of AU2002235786B2 publication Critical patent/AU2002235786B2/en
Assigned to GE HEALTHCARE BIOPROCESS R&D AB reassignment GE HEALTHCARE BIOPROCESS R&D AB Request for Assignment Assignors: GE HEALTHCARE BIO-SCIENCES AB
Assigned to CYTIVA BIOPROCESS R&D AB reassignment CYTIVA BIOPROCESS R&D AB Request to Amend Deed and Register Assignors: GE HEALTHCARE BIOPROCESS R&D AB
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J41/00Anion exchange; Use of material as anion exchangers; Treatment of material for improving the anion exchange properties
    • B01J41/04Processes using organic exchangers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30Processes for preparing, regenerating, or reactivating
    • B01J20/32Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3231Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
    • B01J20/3242Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
    • B01J20/3285Coating or impregnation layers comprising different type of functional groups or interactions, e.g. different ligands in various parts of the sorbent, mixed mode, dual zone, bimodal, multimodal, ionic or hydrophobic, cationic or anionic, hydrophilic or hydrophobic
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/04Processes using organic exchangers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/26Cation exchangers for chromatographic processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J41/00Anion exchange; Use of material as anion exchangers; Treatment of material for improving the anion exchange properties
    • B01J41/20Anion exchangers for chromatographic processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J43/00Amphoteric ion-exchange, i.e. using ion-exchangers having cationic and anionic groups; Use of material as amphoteric ion-exchangers; Treatment of material for improving their amphoteric ion-exchange properties

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Peptides Or Proteins (AREA)
AU2002235786A 2000-12-31 2001-12-17 A method for mixed mode adsorption and mixed mode adsorbents Expired AU2002235786B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0004932-0 2000-12-31
SE0004932A SE0004932D0 (sv) 2000-12-31 2000-12-31 A method for mixed mode adsorption and mixed mode adsorbents
PCT/EP2001/014895 WO2002053252A2 (en) 2000-12-31 2001-12-17 A method for mixed mode adsorption and mixed mode adsorbents

Publications (2)

Publication Number Publication Date
AU2002235786A1 AU2002235786A1 (en) 2003-01-23
AU2002235786B2 true AU2002235786B2 (en) 2006-10-19

Family

ID=20282507

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002235786A Expired AU2002235786B2 (en) 2000-12-31 2001-12-17 A method for mixed mode adsorption and mixed mode adsorbents

Country Status (7)

Country Link
US (1) US7008542B2 (cg-RX-API-DMAC7.html)
EP (1) EP1345695A2 (cg-RX-API-DMAC7.html)
JP (1) JP2004516928A (cg-RX-API-DMAC7.html)
AU (1) AU2002235786B2 (cg-RX-API-DMAC7.html)
CA (1) CA2431012C (cg-RX-API-DMAC7.html)
SE (1) SE0004932D0 (cg-RX-API-DMAC7.html)
WO (1) WO2002053252A2 (cg-RX-API-DMAC7.html)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6908770B1 (en) * 1998-07-16 2005-06-21 Board Of Regents, The University Of Texas System Fluid based analysis of multiple analytes by a sensor array
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
US7214660B2 (en) * 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
CA2515305A1 (en) * 2003-02-07 2004-08-26 John T. Mcdevitt Multi-shell microspheres with integrated chomatographic and detection layers for use in array sensors
US20070026485A1 (en) 2003-04-09 2007-02-01 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
US7943393B2 (en) * 2003-07-14 2011-05-17 Phynexus, Inc. Method and device for extracting an analyte
US9005625B2 (en) 2003-07-25 2015-04-14 Novo Nordisk A/S Antibody toxin conjugates
GB2407783A (en) * 2003-11-07 2005-05-11 Novexin Ltd Chromatographic separation
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
US8101431B2 (en) * 2004-02-27 2012-01-24 Board Of Regents, The University Of Texas System Integration of fluids and reagents into self-contained cartridges containing sensor elements and reagent delivery systems
US8105849B2 (en) * 2004-02-27 2012-01-31 Board Of Regents, The University Of Texas System Integration of fluids and reagents into self-contained cartridges containing sensor elements
EP1771066A2 (en) 2004-07-13 2007-04-11 Neose Technologies, Inc. Branched peg remodeling and glycosylation of glucagon-like peptide-1 glp-1
EP1807205B1 (en) 2004-10-21 2012-09-26 GE Healthcare Bio-Sciences AB A method of antibody purification
JP5948627B2 (ja) 2004-10-29 2016-07-20 レイショファーム ゲーエムベーハー 線維芽細胞成長因子(fgf)のリモデリングと糖質ペグ化
EP1693108A1 (en) * 2004-12-04 2006-08-23 MERCK PATENT GmbH Mixed-modal anion-exchange type separation material
NZ556436A (en) * 2005-01-10 2010-11-26 Biogenerix Ag Glycopegylated granulocyte colony stimulating factor
WO2006121569A2 (en) * 2005-04-08 2006-11-16 Neose Technologies, Inc. Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
WO2006127973A2 (en) * 2005-05-24 2006-11-30 Waters Inverstments Limited Methods for separating and analyzing anionic compounds
AU2006309284B2 (en) 2005-05-31 2012-08-02 Board Of Regents, The University Of Texas System Methods and compositions related to determination and use of white blood cell counts
US20070105755A1 (en) * 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
US20090048440A1 (en) 2005-11-03 2009-02-19 Neose Technologies, Inc. Nucleotide Sugar Purification Using Membranes
WO2007092827A2 (en) 2006-02-08 2007-08-16 Waters Investments Limited Improved separation method
US9375499B2 (en) * 2006-07-14 2016-06-28 Wisconsin Alumni Research Foundation Adsorptive membranes for trapping viruses
US20080248959A1 (en) * 2006-07-21 2008-10-09 Neose Technologies, Inc. Glycosylation of peptides via o-linked glycosylation sequences
EP2054521A4 (en) * 2006-10-03 2012-12-19 Novo Nordisk As PROCESS FOR CLEANING POLYPEPTIDE CONJUGATES
HUE036502T2 (hu) * 2006-10-04 2018-07-30 Novo Nordisk As Glicerinhez kapcsolódó pegilált cukrok és glükopeptidek
US20080207487A1 (en) * 2006-11-02 2008-08-28 Neose Technologies, Inc. Manufacturing process for the production of polypeptides expressed in insect cell-lines
US7999085B2 (en) * 2007-01-09 2011-08-16 Bio-Rad Laboratories, Inc. Enhanced capacity and purification of protein by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
US7691980B2 (en) 2007-01-09 2010-04-06 Bio-Rad Laboratories, Inc. Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
US9050304B2 (en) * 2007-04-03 2015-06-09 Ratiopharm Gmbh Methods of treatment using glycopegylated G-CSF
WO2008154639A2 (en) 2007-06-12 2008-12-18 Neose Technologies, Inc. Improved process for the production of nucleotide sugars
EP2167229A4 (en) * 2007-07-25 2012-02-01 Ge Healthcare Bio Sciences Ab SEPARATION MATRIX
EP2242505A4 (en) * 2008-01-08 2012-03-07 Biogenerix Ag GLYCOCONJUGATION OF POLYPEPTIDES USING OLIGOSACCHARYLTRANSFERASES
ES2476690T3 (es) 2008-02-27 2014-07-15 Novo Nordisk A/S Moléculas conjugadas del Factor VIII
EP2265129B1 (en) * 2008-04-08 2015-10-28 Bio-Rad Laboratories, Inc. Chromatography purification of antibodies
SG178173A1 (en) * 2009-07-28 2012-03-29 Instraction Gmbh Specific sorbent for binding proteins and peptides, and separation method using the same
JP5826180B2 (ja) * 2009-10-12 2015-12-02 ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ 分離マトリックス
CN102762268B (zh) 2009-12-07 2015-07-08 弗雷塞尼斯医疗保健控股公司 使用锆离子交换吸附剂的水净化筒
US9061267B2 (en) * 2009-12-17 2015-06-23 Instraction Gmbh Specific sorbent for binding proteins and peptides, and separation method using the same
EP2674753B1 (en) * 2011-02-10 2020-05-13 Sekisui Medical Co., Ltd. Method for separating and detecting a nucleic acid strand
JP2012211110A (ja) * 2011-03-31 2012-11-01 Asahi Kasei Medical Co Ltd 多孔質吸着膜
EP2570181A1 (en) * 2011-09-15 2013-03-20 InstrAction GmbH Sorbent comprising its surface an aliphatic unit having an anionic or deprotonizable group for the purfication of organic molecules
GB2521524B (en) 2012-05-15 2018-12-05 Waters Technologies Corp Chromatographic materials
WO2013180649A1 (en) * 2012-05-31 2013-12-05 Agency For Science, Technology And Research Mixed multifunctional metal affinity surfaces for reducing aggregate content in protein preparations field
JP6469574B2 (ja) * 2012-09-17 2019-02-13 ダブリュー・アール・グレース・アンド・カンパニー−コーンW R Grace & Co−Conn 官能化粒状保持体ならびにその製造法及び使用法
IN2015DN02055A (cg-RX-API-DMAC7.html) 2012-09-17 2015-08-14 Grace W R & Co
JP2016513245A (ja) * 2013-02-06 2016-05-12 エイジェンシー・フォー・サイエンス,テクノロジー・アンド・リサーチ タンパク質製剤の凝集体含有量を減少させる混合多官能金属親和性表面
US10023608B1 (en) 2013-03-13 2018-07-17 Amgen Inc. Protein purification methods to remove impurities
EP3094390B1 (en) 2014-01-16 2021-07-07 W.R. Grace & CO. - CONN. Affinity chromatography media and chromatography devices
PL3137209T3 (pl) 2014-05-02 2023-01-02 W.R. Grace & Co. - Conn. Funkcjonalizowany materiał nośnikowy i sposoby wytwarzania oraz stosowania funkcjonalizowanego materiału nośnikowego
PL3302784T3 (pl) 2015-06-05 2022-01-17 W.R. Grace & Co.-Conn. Adsorbentowe środki klarujące do bioprzetwarzania oraz sposoby ich wytwarzania i stosowania
CN110844886A (zh) * 2019-12-02 2020-02-28 锦西化工研究院有限公司 一种二硫化钠水溶液的合成方法
CN111617747B (zh) * 2020-05-11 2022-05-31 贵州大学 一种壳聚糖/纳米金属复合水凝胶及其制备方法和应用
US11731108B2 (en) * 2021-03-17 2023-08-22 Bio-Rad Laboratories, Inc. Mixed mode cation exchange chromatography ligands based on 1,3-dioxoisoindolin-2-yl structures

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767670A (en) * 1987-01-21 1988-08-30 E. I. Du Pont De Nemours And Company Chromatographic supports for separation of oligonucleotides
JPH0564748A (ja) * 1991-09-06 1993-03-19 Tosoh Corp イオン交換体
US5652348A (en) * 1994-09-23 1997-07-29 Massey University Chromatographic resins and methods for using same
SE9600590D0 (sv) 1996-02-19 1996-02-19 Pharmacia Biotech Ab Sätt för kromatografisk separation av peptider och nukleinsyra samt ny högaffin jonbytesmatris
SE9802214D0 (sv) 1998-06-18 1998-06-18 Amersham Pharm Biotech Ab Jonbytare och användning därav
US6310199B1 (en) 1999-05-14 2001-10-30 Promega Corporation pH dependent ion exchange matrix and method of use in the isolation of nucleic acids
SE9904197D0 (sv) 1999-11-22 1999-11-22 Amersham Pharm Biotech Ab A method for anion exchange adsorption on matrices carrying mixed mode ligands

Also Published As

Publication number Publication date
CA2431012C (en) 2011-08-16
US20040020857A1 (en) 2004-02-05
CA2431012A1 (en) 2002-07-11
WO2002053252A2 (en) 2002-07-11
SE0004932D0 (sv) 2000-12-31
WO2002053252A3 (en) 2002-09-26
US7008542B2 (en) 2006-03-07
EP1345695A2 (en) 2003-09-24
JP2004516928A (ja) 2004-06-10

Similar Documents

Publication Publication Date Title
AU2002235786B2 (en) A method for mixed mode adsorption and mixed mode adsorbents
AU2002235786A1 (en) A method for mixed mode adsorption and mixed mode adsorbents
AU780286B2 (en) A method for anion-exchange adsorption and thioether anion-exchangers
JP2004516928A5 (cg-RX-API-DMAC7.html)
EP1345694B1 (en) A method for the manufacture of compositions containing low concentrations of salts
CA2460355C (en) Generation of ion exchanger media
JP2004532182A5 (cg-RX-API-DMAC7.html)
CA2412586C (en) Adsorption method and ligands
JP4643006B2 (ja) カチオン交換体による分離方法
US20050267295A1 (en) Method for selective removal of a substance from samples containing compounds having nucleic acid structure
Agreda et al. RESINS AS BIOSORBENTS: ION EXCHANGE

Legal Events

Date Code Title Description
TC Change of applicant's name (sec. 104)

Owner name: GE HEALTHCARE BIO-SCIENCES AB

Free format text: FORMER NAME: AMERSHAM BIOSCIENCES AB

FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: GE HEALTHCARE BIOPROCESS R&D AB

Free format text: FORMER OWNER WAS: GE HEALTHCARE BIO-SCIENCES AB

HB Alteration of name in register

Owner name: CYTIVA BIOPROCESS R&D AB

Free format text: FORMER NAME(S): GE HEALTHCARE BIOPROCESS R&D AB

MK14 Patent ceased section 143(a) (annual fees not paid) or expired